IL287243A - Triple helix terminator for efficient rna trans-splicing - Google Patents
Triple helix terminator for efficient rna trans-splicingInfo
- Publication number
- IL287243A IL287243A IL287243A IL28724321A IL287243A IL 287243 A IL287243 A IL 287243A IL 287243 A IL287243 A IL 287243A IL 28724321 A IL28724321 A IL 28724321A IL 287243 A IL287243 A IL 287243A
- Authority
- IL
- Israel
- Prior art keywords
- terminates
- triple helix
- rna splicing
- efficient trans
- trans rna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/33—Alteration of splicing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/36—Vector systems having a special element relevant for transcription being a transcription termination element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/48—Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Ophthalmology & Optometry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962835164P | 2019-04-17 | 2019-04-17 | |
| PCT/US2020/028797 WO2020214973A1 (en) | 2019-04-17 | 2020-04-17 | Triple helix terminator for efficient rna trans-splicing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL287243A true IL287243A (en) | 2021-12-01 |
Family
ID=72837942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL287243A IL287243A (en) | 2019-04-17 | 2021-10-13 | Triple helix terminator for efficient rna trans-splicing |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220204989A1 (enExample) |
| EP (1) | EP3956442A4 (enExample) |
| JP (2) | JP2022529065A (enExample) |
| KR (1) | KR20220002910A (enExample) |
| CN (1) | CN114040974B (enExample) |
| BR (1) | BR112021020539A2 (enExample) |
| CA (1) | CA3133555A1 (enExample) |
| IL (1) | IL287243A (enExample) |
| MX (1) | MX2021012702A (enExample) |
| WO (1) | WO2020214973A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020010959A (es) | 2018-04-17 | 2021-01-15 | Univ Pennsylvania | Moleculas de empalme trans. |
| CN114040974B (zh) * | 2019-04-17 | 2025-11-04 | 宾夕法尼亚州大学信托人 | 用于高效rna反式剪接的三螺旋终止子 |
| AU2022259416A1 (en) * | 2021-04-15 | 2023-11-16 | Tacit Therapeutics, Inc. | High efficiency trans-splicing for replacement of targeted rna sequences in human cells |
| IL311101A (en) | 2021-09-03 | 2024-04-01 | Tacit Therapeutics Inc | RNA editing through recruitment of SPLICEOSOME components |
| WO2023205694A2 (en) * | 2022-04-20 | 2023-10-26 | Tacit Therapeutics, Inc. | Stabilization of therapeutic trans-splicing rna molecules in human cells |
| US20250290067A1 (en) * | 2022-05-03 | 2025-09-18 | Tacit Therapeutics, Inc. | Localization of trans-splicing nucleic acid molecules to and within the cellular nucleus |
| IL316944A (en) * | 2022-05-13 | 2025-01-01 | Ascidian Therapeutics Inc | ABCA4 cross-linking molecules |
| EP4622662A1 (en) | 2022-11-23 | 2025-10-01 | Amber Bio Inc. | Gene-modifying endonucleases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2151248A1 (en) * | 2008-07-30 | 2010-02-10 | Johann Bauer | Improved pre-mRNA trans-splicing molecule (RTM) molecules and their uses |
| CN104955951A (zh) * | 2012-10-16 | 2015-09-30 | 麻省理工学院 | 稳定的非多腺苷酸化rna的产生 |
| GB201219762D0 (en) * | 2012-11-02 | 2012-12-19 | Bauer Johann | A RNA trans-splicing molecule (RTM) for use in the treatment of cancer |
| EP2986635B1 (en) * | 2013-04-18 | 2018-10-03 | Fondazione Telethon | Effective delivery of large genes by dual aav vectors |
| AU2016355343C1 (en) * | 2015-11-19 | 2024-10-03 | Lloyd G. Mitchell | Compositions and methods for correction of heritable ocular disease |
| WO2019027869A1 (en) * | 2017-07-31 | 2019-02-07 | Massachusetts Institute Of Technology | RNA-CLUSTER INDUCED TRANSCRIPT STABILIZER AND USES THEREOF |
| MX2020010959A (es) * | 2018-04-17 | 2021-01-15 | Univ Pennsylvania | Moleculas de empalme trans. |
| CN114040974B (zh) * | 2019-04-17 | 2025-11-04 | 宾夕法尼亚州大学信托人 | 用于高效rna反式剪接的三螺旋终止子 |
-
2020
- 2020-04-17 CN CN202080044745.1A patent/CN114040974B/zh active Active
- 2020-04-17 WO PCT/US2020/028797 patent/WO2020214973A1/en not_active Ceased
- 2020-04-17 CA CA3133555A patent/CA3133555A1/en active Pending
- 2020-04-17 MX MX2021012702A patent/MX2021012702A/es unknown
- 2020-04-17 US US17/604,228 patent/US20220204989A1/en active Pending
- 2020-04-17 BR BR112021020539A patent/BR112021020539A2/pt unknown
- 2020-04-17 JP JP2021561943A patent/JP2022529065A/ja active Pending
- 2020-04-17 KR KR1020217034092A patent/KR20220002910A/ko active Pending
- 2020-04-17 EP EP20791307.0A patent/EP3956442A4/en active Pending
-
2021
- 2021-10-13 IL IL287243A patent/IL287243A/en unknown
-
2025
- 2025-05-08 JP JP2025077741A patent/JP2025121988A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021012702A (es) | 2022-01-24 |
| CN114040974B (zh) | 2025-11-04 |
| JP2025121988A (ja) | 2025-08-20 |
| CA3133555A1 (en) | 2020-10-22 |
| BR112021020539A2 (pt) | 2022-01-04 |
| US20220204989A1 (en) | 2022-06-30 |
| EP3956442A1 (en) | 2022-02-23 |
| JP2022529065A (ja) | 2022-06-16 |
| EP3956442A4 (en) | 2023-01-25 |
| AU2020260154A1 (en) | 2021-11-11 |
| WO2020214973A1 (en) | 2020-10-22 |
| CN114040974A (zh) | 2022-02-11 |
| KR20220002910A (ko) | 2022-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3791815C0 (en) | EXPANDABLE MOUTHPIECE CATHETER | |
| EP3926701A4 (en) | Display panel | |
| EP4003212A4 (en) | Fiducial marker | |
| EP3956442A4 (en) | TRIPLE HELIX TERMINATOR FOR EFFICIENT RNA TRANSSPLICING | |
| UA42369S (uk) | Комп'ютер | |
| DK3952973T3 (da) | Genanvendelige urinkateterprodukter | |
| DK4034181T3 (da) | Genanvendelige urinkateterprodukter | |
| EP3900510A4 (en) | DRIVING MACHINE | |
| EP3982415A4 (en) | SHOWBOARD | |
| EP3952929C0 (en) | PRODUCTS FOR REUSABLE URINARY CATHETERS | |
| IL286329A (en) | Manufacturing a reflective diffraction grating | |
| IL291466A (en) | Mrna encoding engineered cftr | |
| PL4058622T3 (pl) | Sieć nanodrutów | |
| DK3825470T3 (da) | Fugnings metode | |
| DK4034178T3 (da) | Genanvendelige urinkateterprodukter | |
| EP4045119A4 (en) | Endotracheal tube | |
| IL286630A (en) | Method of introducing target-specific foreign gene | |
| EP4072616C0 (en) | TUBE MARKERS | |
| EP4055759C0 (en) | Coreset search area optimization | |
| EP3972676C0 (en) | ENDOTRACHEAL TUBE | |
| EP3822075C0 (de) | Tube | |
| DK3931815T3 (da) | A label | |
| UA40706S (uk) | Келих «весільний» | |
| CA194390S (fr) | Gomme à éffacer | |
| UA40283S (uk) | Рекламна арка |